Enlivex Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Enlivex Therapeutics (ENLV) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Enlivex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enlivex Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enlivex Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $245k | 219k | 1.12 |
| 2024-12-31 | $316k | 270k | 1.17 |
| 2024-09-30 | $413k | 246k | 1.68 |
| 2024-06-30 | $348k | 245k | 1.42 |
| 2024-03-31 | $273k | 72k | 3.79 |
| 2023-12-31 | $120k | 45k | 2.70 |
| 2023-09-30 | $70k | 44k | 1.58 |
| 2023-06-30 | $115k | 44k | 2.63 |
| 2022-12-31 | $160k | 41k | 3.94 |
| 2022-06-30 | $148k | 33k | 4.52 |
| 2022-03-31 | $121k | 22k | 5.61 |
| 2021-06-30 | $126k | 14k | 8.93 |
| 2020-12-31 | $24k | 2.8k | 8.55 |
| 2020-06-30 | $0 | 2 | 0.00 |
| 2020-03-31 | $132k | 28k | 4.69 |
| 2019-12-31 | $0 | 2 | 0.00 |
| 2019-09-30 | $0 | 2 | 0.00 |
| 2019-03-31 | $0 | 2 | 0.00 |